Position in NVO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$293,153
+$81,841 QoQ
Shares Held
6,115
+6.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#901
of 1,348 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Berkeley Capital Partners, LLC holds $14,092,981 across 9 Drug Manufacturers - General names. NVO ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,370 | $3,141,608 | |
| 2 | MRK |
Merck & Co., Inc.
|
17,441 | $2,241,168 | |
| 3 | ABBV |
AbbVie Inc.
|
7,720 | $1,942,660 | |
| 4 | LLY |
ELI LILLY & Co
|
1,361 | $1,632,424 | |
| 5 | NVS |
Novartis AG
|
10,041 | $1,573,625 | |
| 6 | PFE |
Pfizer Inc
|
64,286 | $1,548,006 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,331 | $1,459,572 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
6,115 | $293,153 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $293,153 | 6,115 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $211,312 | 5,750 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $280,094 | 5,505 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $214,413 | 3,864 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||